ONCO/REVEAL Trademark

Trademark Overview


On Friday, September 22, 2017, a trademark application was filed for ONCO/REVEAL with the United States Patent and Trademark Office. The USPTO has given the ONCO/REVEAL trademark a serial number of 87982295. The federal status of this trademark filing is REGISTERED as of Tuesday, July 28, 2020. This trademark is owned by Pillar Biosciences, Inc.. The ONCO/REVEAL trademark is filed in the Chemical Products, Pharmaceutical Products, and Computer & Software Products & Electrical & Scientific Products categories with the following description:

Computer software for the collection, management, and analysis of data for use in the fields of scientific research, clinical research, scientific diagnostics, and medical diagnostics; computer software for analyzing biological samples; computer software for analyzing biological samples for medical purposes, namely, for the diagnosis and treatment of cancer; computer software for use with reagents and reagent kits, all for use in detecting, sequencing, and analyzing nucleic acids and other biological molecules, samples of biological molecules, genes, genomes, nucleotide sequence variants and modifications, all in the fields of scientific research, clinical research, scientific diagnostics research, and medical diagnostics; computer software for bioinformatics and gene expression microarray image analysis, namely, gene expression quantification, gene image processing, and gene information processing

Reagents and reagent kits comprising nucleic acids, naturally occurring and modified nucleotides, enzymes, buffers, and adhesive reagent labels, all for the purpose of preparing, detecting, sequencing, and analyzing nucleic acids and other biological molecules, samples of biological molecules, genes, genomes, nucleotide sequence variants and modifications, regulations, transcriptions, and expressions, with the aforementioned reagents and reagent kits being for medical diagnostic purposes; Biological and biochemical reagents used for selectively amplifying nucleic acid fragments, with the aforementioned reagents being used for medical diagnostic purposes; Biological and biochemical kits comprised of diagnostic preparations for medical purposes, namely, for the diagnosis and treatment of cancer

Reagents and reagent kits comprising nucleic acids, naturally occurring and modified nucleotides, enzymes, buffers, and adhesive reagent labels, all for the purpose of preparing, detecting, sequencing, and analyzing nucleic acids and other biological molecules, samples of biological molecules, genes, genomes, nucleotide sequence variants and modifications, regulations, transcriptions, and expressions, with the aforementioned reagents and reagent kits being in the fields of scientific research, clinical research, and scientific diagnostics research; Biological and biochemical reagents used for selectively amplifying nucleic acid fragments for scientific research, clinical research, and scientific diagnostics research
onco/reveal

General Information


Serial Number87982295
Word MarkONCO/REVEAL
Filing DateFriday, September 22, 2017
Status700 - REGISTERED
Status DateTuesday, July 28, 2020
Registration Number6114090
Registration DateTuesday, July 28, 2020
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 20, 2018

Trademark Statements


Goods and ServicesComputer software for the collection, management, and analysis of data for use in the fields of scientific research, clinical research, scientific diagnostics, and medical diagnostics; computer software for analyzing biological samples; computer software for analyzing biological samples for medical purposes, namely, for the diagnosis and treatment of cancer; computer software for use with reagents and reagent kits, all for use in detecting, sequencing, and analyzing nucleic acids and other biological molecules, samples of biological molecules, genes, genomes, nucleotide sequence variants and modifications, all in the fields of scientific research, clinical research, scientific diagnostics research, and medical diagnostics; computer software for bioinformatics and gene expression microarray image analysis, namely, gene expression quantification, gene image processing, and gene information processing
Goods and ServicesReagents and reagent kits comprising nucleic acids, naturally occurring and modified nucleotides, enzymes, buffers, and adhesive reagent labels, all for the purpose of preparing, detecting, sequencing, and analyzing nucleic acids and other biological molecules, samples of biological molecules, genes, genomes, nucleotide sequence variants and modifications, regulations, transcriptions, and expressions, with the aforementioned reagents and reagent kits being for medical diagnostic purposes; Biological and biochemical reagents used for selectively amplifying nucleic acid fragments, with the aforementioned reagents being used for medical diagnostic purposes; Biological and biochemical kits comprised of diagnostic preparations for medical purposes, namely, for the diagnosis and treatment of cancer
Pseudo MarkON CO/REVEAL
Goods and ServicesReagents and reagent kits comprising nucleic acids, naturally occurring and modified nucleotides, enzymes, buffers, and adhesive reagent labels, all for the purpose of preparing, detecting, sequencing, and analyzing nucleic acids and other biological molecules, samples of biological molecules, genes, genomes, nucleotide sequence variants and modifications, regulations, transcriptions, and expressions, with the aforementioned reagents and reagent kits being in the fields of scientific research, clinical research, and scientific diagnostics research; Biological and biochemical reagents used for selectively amplifying nucleic acid fragments for scientific research, clinical research, and scientific diagnostics research

Classification Information


International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateThursday, September 28, 2017
Primary Code001
First Use Anywhere DateMonday, May 20, 2019
First Use In Commerce DateMonday, May 20, 2019

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, September 28, 2017
Primary Code005
First Use Anywhere DateMonday, August 26, 2019
First Use In Commerce DateMonday, August 26, 2019

International Class009 - Scientific, nautical, surveying, photographic, cinematographic, optical, weighing, measuring, signalling, checking (supervision), life-saving and teaching apparatus and instruments; apparatus and instruments for conducting, switching, transforming, accumulating, regulating or controlling electricity; apparatus for recording, transmission or reproduction of sound or images; magnetic data carriers, recording discs; automatic vending machines and mechanisms for coin operated apparatus; cash registers, calculating machines, data processing equipment and computers; fire extinguishing apparatus.
US Class Codes021, 023, 026, 036, 038
Class Status Code6 - Active
Class Status DateThursday, September 28, 2017
Primary Code009
First Use Anywhere DateMonday, August 26, 2019
First Use In Commerce DateMonday, August 26, 2019

Trademark Owner History


Party NamePillar Biosciences, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressNatick, MA 01760

Party NamePillar Biosciences, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNatick, MA 01760

Party NamePillar Biosciences, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNatick, MA 01760

Trademark Events


Event DateEvent Description
Thursday, January 4, 2018NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, September 26, 2017NEW APPLICATION ENTERED
Thursday, September 28, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, December 28, 2017ASSIGNED TO EXAMINER
Thursday, January 4, 2018NON-FINAL ACTION E-MAILED
Thursday, January 4, 2018NON-FINAL ACTION WRITTEN
Wednesday, January 24, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, January 24, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, January 25, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, February 8, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, February 28, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 20, 2018PUBLISHED FOR OPPOSITION
Tuesday, March 20, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 15, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, November 15, 2018SOU TEAS EXTENSION RECEIVED
Thursday, November 15, 2018SOU EXTENSION 1 FILED
Thursday, November 15, 2018SOU EXTENSION 1 GRANTED
Saturday, November 17, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, May 10, 2019SOU TEAS EXTENSION RECEIVED
Friday, May 10, 2019TEAS REQUEST TO DIVIDE RECEIVED
Wednesday, May 29, 2019SOU EXTENSION 2 GRANTED
Friday, May 10, 2019SOU EXTENSION 2 FILED
Friday, May 10, 2019DIVISIONAL REQUEST RECEIVED
Wednesday, May 29, 2019CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, May 29, 2019DIVISIONAL PROCESSING COMPLETE
Thursday, May 30, 2019CORRECTED NOA E-MAILED
Thursday, May 30, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, November 11, 2019TEAS STATEMENT OF USE RECEIVED
Monday, November 11, 2019SOU TEAS EXTENSION RECEIVED
Monday, November 11, 2019TEAS REQUEST TO DIVIDE RECEIVED
Monday, November 11, 2019SOU EXTENSION 3 FILED
Monday, November 11, 2019DIVISIONAL REQUEST RECEIVED
Wednesday, November 13, 2019SOU EXTENSION 3 GRANTED
Wednesday, November 13, 2019DIVISIONAL PROCESSING COMPLETE
Monday, November 11, 2019USE AMENDMENT FILED
Wednesday, November 13, 2019STATEMENT OF USE PROCESSING COMPLETE
Thursday, November 14, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, November 26, 2019SU - NON-FINAL ACTION - WRITTEN
Tuesday, November 26, 2019NON-FINAL ACTION E-MAILED
Tuesday, November 26, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, May 21, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, May 29, 2020ASSIGNED TO LIE
Tuesday, June 2, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, June 2, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, June 25, 2020ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Friday, June 26, 2020NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, July 28, 2020REGISTERED-PRINCIPAL REGISTER
Monday, July 28, 2025COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED